机译:Pembrolizumab在CLL和RICHTER转换或复发CLL患者中
Mayo Clin Div Hematol 200 First St SW Rochester MN 55905 USA;
Mayo Clin Dept Hlth Sci Res Rochester MN USA;
Mayo Clin Div Hematol 200 First St SW Rochester MN 55905 USA;
Mayo Clin Div Hematol 200 First St SW Rochester MN 55905 USA;
Mayo Clin Dept Hematol &
Oncol Scottsdale AZ USA;
Mayo Clin Div Hematopathol Rochester MN USA;
Mayo Clin Div Hematol 200 First St SW Rochester MN 55905 USA;
Mayo Clin Div Hematol 200 First St SW Rochester MN 55905 USA;
Mayo Clin Dept Hlth Sci Res Rochester MN USA;
Mayo Clin Div Hematopathol Rochester MN USA;
Mayo Clin Div Hematol 200 First St SW Rochester MN 55905 USA;
Mayo Clin Div Hematol 200 First St SW Rochester MN 55905 USA;
Mayo Clin Dept Radiol Rochester MN USA;
Mayo Clin Div Hematol 200 First St SW Rochester MN 55905 USA;
Mayo Clin Dept Hlth Sci Res Rochester MN USA;
Mayo Clin Div Hematol 200 First St SW Rochester MN 55905 USA;
Mayo Clin Div Hematol 200 First St SW Rochester MN 55905 USA;
Mayo Clin Div Hematol 200 First St SW Rochester MN 55905 USA;
Mayo Clin Div Hematol 200 First St SW Rochester MN 55905 USA;
Mayo Clin Dept Lab Med &
Pathol Rochester MN USA;
Mayo Clin Dept Lab Med &
Pathol Rochester MN USA;
Mayo Clin Dept Immunol Rochester MN USA;
Mayo Clin Div Hematol 200 First St SW Rochester MN 55905 USA;
Mayo Clin Div Hematol 200 First St SW Rochester MN 55905 USA;
Mayo Clin Div Hematol 200 First St SW Rochester MN 55905 USA;
Mayo Clin Dept Hlth Sci Res Rochester MN USA;
Mayo Clin Dept Hematol &
Oncol Scottsdale AZ USA;
Mayo Clin Div Hematol 200 First St SW Rochester MN 55905 USA;
Mayo Clin Div Hematol 200 First St SW Rochester MN 55905 USA;
Mayo Clin Div Hematopathol Rochester MN USA;
Mayo Clin Dept Hlth Sci Res Rochester MN USA;
Mayo Clin Div Hematol Jacksonville FL 32224 USA;
Mayo Clin Div Hematol 200 First St SW Rochester MN 55905 USA;
Mayo Clin Dept Immunol Rochester MN USA;
Mayo Clin Div Hematol 200 First St SW Rochester MN 55905 USA;
机译:Pembrolizumab在CLL和RICHTER转换或复发CLL患者中
机译:在复发或难发的NHL和CLL中的CD19-靶向19-28Z / 4-1BBL“装甲”CAR T细胞的一期第一阶段临床试验,包括Rictter的转化
机译:Hodgkin在一系列CLL CLL患者中伊布洛替尼治疗期间Richter的转化变体; 波兰成人白血病集团报告(Palg Palg)
机译:B-Cell慢性淋巴细胞白血病(CLL) - 渗透多中心研究的复发/抗性患者复发/抗性患者的氟氮胺碱和环磷酰胺联合治疗的效率和毒性
机译:SMZL表型病因最近最似乎在关键方面的记忆B细胞和Parallels CLL
机译:Pembrolizumab用于CLL和Richter转化或CLL复发的患者
机译:Pembrolizumab在CLL和RICHTER转换或复发CLL患者中